Date: 2025/05/18 - 16:31
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.
Date: 2025/05/17 - 01:32
“Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be much more common in women, men may be significantly more likely to die from it, according to new research.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.
Date: 2025/05/15 - 19:00
Three months of 8-hour time-restricted eating (TRE), regardless of the time of the day, helped sustain long-term weight loss in adults with overweight or obesity, preliminary results from a clinical trial has shown.